James Hardie: A Year of Revenue Beats Meets the Quarter Analysts Stopped Raising Estimates
James Hardie Industries (JHX) reports fiscal Q4 2026 earnings after the close on May 19, 2026, with analysts expecting $0.29 per share on the heels of two consecutive quarterly beats. The central question: can the building materials manufacturer sustain momentum amid a challenging year-over-year comparison and recent estimate revisions that have trimmed full-year expectations by 27%? With the stock trading nearly 7% below its 200-day moving average and technical signals flashing caution, this report will test whether operational execution can overcome a deteriorating technical backdrop.
Part 1: Earnings Preview
James Hardie Industries manufactures fiber cement building products, primarily serving the residential and commercial construction markets across North America, Australia, and Europe. The company is a leading supplier of exterior siding and interior wall systems, with performance closely tied to housing starts and renovation activity.
JHX reports fiscal Q4 2026 results after the close on May 19, 2026, with the consensus estimate calling for $0.29 per share on revenue of approximately $1.42 billion. The company most recently reported $0.24 per share for fiscal Q3 2026 (quarter ending December 2025), beating estimates by 4.35%. However, the upcoming quarter faces a tougher comparison: analysts expect 19.44% year-over-year decline versus the $0.36 reported in the same quarter last year (March 2025).
Three key themes define this earnings story:
Volume Recovery vs. Pricing Pressure — Investors will scrutinize whether housing market stabilization is translating into volume gains that can offset margin compression. Revenue estimates suggest strong top-line growth (+45.93% year-over-year), but the EPS decline indicates profitability headwinds that management must address.
Geographic Mix and Market Share — With operations spanning multiple continents, the balance between North American residential strength, Australian market conditions, and European exposure will shape the narrative. Analysts are watching whether the company can maintain its competitive positioning as construction activity varies by region.
Full-Year Guidance Reset — Consensus estimates for fiscal 2026 have been revised down significantly (from $1.49 to $1.09), reflecting a 26.85% year-over-year decline. Management's commentary on the path back to growth in fiscal 2027 (where estimates call for 22% EPS growth to $1.33) will be critical for investor confidence.
Analyst commentary ahead of the release reflects cautious optimism tempered by near-term headwinds. The 11 Strong Buy ratings (out of 16 total analysts) demonstrate conviction in the long-term story, with a mean price target of $28.04 implying substantial upside. However, recent estimate revisions lower suggest analysts are recalibrating expectations for the pace of recovery.
Part 2: Historical Earnings Performance
James Hardie has delivered a mixed earnings track record over the past four quarters, with two beats and two misses against consensus estimates. The company beat expectations in the two most recent quarters — posting $0.24 versus $0.23 expected in Q3 2026 (December quarter) and $0.26 versus $0.25 in Q2 2026 (September quarter) — demonstrating improving execution in the back half of the fiscal year.
However, the prior two quarters showed significant misses: Q1 2026 (June quarter) came in at $0.29 against a $0.36 estimate (a 19.44% shortfall), and Q4 2025 (March quarter) delivered $0.36 versus $0.37 expected. The magnitude of the Q1 2026 miss stands out as particularly notable, representing the largest earnings disappointment in this four-quarter window.
The pattern suggests a company that stumbled mid-year but has since stabilized, with consecutive modest beats in the most recent two quarters. The surprise percentages have been relatively small in both directions (ranging from -19.44% to +4.35%), indicating that estimates have generally been in the ballpark. Heading into Q4 2026, the recent trend of small beats provides some confidence, though the year-over-year comparison remains challenging with estimates calling for a 19.44% decline from the prior-year quarter.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $0.37 | $0.36 | -2.70% | Miss |
| Jun 2025 | $0.36 | $0.29 | -19.44% | Miss |
| Sep 2025 | $0.25 | $0.26 | +4.00% | Beat |
| Dec 2025 | $0.23 | $0.24 | +4.35% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
James Hardie reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 represents the first full session of market reaction to the actual earnings.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-02-10 | +$0.98 (+4.19%) | $1.10 (4.70%) | +$1.62 (+6.64%) | $1.75 (7.18%) |
| 2025-11-17 | +$0.00 (+0.00%) | $0.45 (2.71%) | +$1.14 (+6.83%) | $0.96 (5.75%) |
| 2025-08-19 | -$0.47 (-1.63%) | $0.71 (2.46%) | -$9.79 (-34.44%) | $2.59 (9.09%) |
| 2025-05-20 | -$0.52 (-2.06%) | $0.44 (1.74%) | -$0.86 (-3.48%) | $1.40 (5.68%) |
| 2025-02-18 | -$0.66 (-2.03%) | $1.05 (3.23%) | +$0.82 (+2.58%) | $0.75 (2.36%) |
| 2024-11-13 | +$2.82 (+8.87%) | $1.30 (4.09%) | +$0.56 (+1.62%) | $0.99 (2.86%) |
| 2024-11-12 | -$0.90 (-2.75%) | $1.48 (4.53%) | +$2.82 (+8.87%) | $1.30 (4.09%) |
| 2024-08-12 | -$0.52 (-1.60%) | $0.93 (2.88%) | -$0.21 (-0.66%) | $0.89 (2.78%) |
| Avg Abs Move | 2.89% | 3.29% | 8.14% | 4.97% |
Historical price action around JHX earnings shows significant volatility, with an average absolute Day 0 move of 2.89% and Day +1 move of 8.14%. The Day +1 reaction has been particularly pronounced, nearly triple the Day 0 anticipatory move, suggesting that the market waits for actual results before making major positioning decisions.
The most recent earnings release (February 2026) produced a strong positive reaction, with the stock gaining 4.19% on Day 0 and extending to a 6.64% gain by Day +1. This followed the company's beat on estimates and marked a sharp contrast to the August 2025 report, which triggered a dramatic 34.44% Day +1 decline — the largest move in the dataset and likely reflecting the significant earnings miss that quarter.
Directional consistency has been limited, with Day +1 moves ranging from -34.44% to +8.87%, indicating that JHX can produce outsized reactions in either direction depending on results and guidance. The average Day +1 range of 4.97% suggests typical intraday volatility during the reaction session is substantial. Investors should prepare for meaningful price movement, particularly on the day following the after-close release.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 06/18/26 (DTE 31) |
| Expected Move | $2.75 (13.85%) |
| Expected Range | $17.07 to $22.57 |
| Implied Volatility | 62.26% |
The options market is pricing an expected move of 13.85% (±$2.75) for the June monthly expiration, which is substantially higher than the historical average Day +1 move of 8.14%. This elevated implied volatility suggests options traders are anticipating a larger-than-typical reaction to this earnings report, possibly reflecting uncertainty around guidance and the challenging year-over-year comparison.
Part 3: What Analysts Are Saying
Analyst sentiment on James Hardie remains decidedly bullish, with an average recommendation of 4.38 out of 5.0 (between Buy and Strong Buy) and a consensus price target of $28.04. This target implies 41.4% upside from the current price of $19.82, reflecting confidence in the company's long-term value proposition despite near-term headwinds.
The rating breakdown shows strong conviction: 11 of 16 analysts rate JHX a Strong Buy, with zero Sell or Strong Sell ratings. The remaining 5 analysts maintain Hold ratings, suggesting even the cautious camp sees limited downside risk. The price target range spans from $22.00 to $30.00, with the low-end target still implying 11% upside from current levels.
Sentiment has remained unchanged over the past month, with the analyst count and average recommendation holding steady at 4.38. This stability suggests the analyst community has already incorporated recent estimate revisions into their views and is maintaining conviction despite the stock's recent weakness. The lack of downgrades even as estimates have been trimmed indicates analysts view current challenges as cyclical rather than structural, with the business model and competitive position intact for the anticipated recovery in fiscal 2027.
Part 4: Technical Picture
The Barchart Technical Opinion rates JHX as 64% Sell, reflecting deteriorating technical momentum heading into earnings. This represents a meaningful shift from one month ago when the signal was neutral (0% Hold) and has weakened further from last week's 56% Sell reading, indicating accelerating negative momentum in the near term.
Timeframe Analysis:
- Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative, though not at extreme levels
- Medium-term (100% Sell): Strong sell signal across the intermediate timeframe reflects sustained weakness and suggests the trend has firmly shifted bearish
- Long-term (50% Sell): Moderate sell signal in the longer-term view indicates the broader trend has also deteriorated from previous strength
Trend Characteristics: The combination of Weak strength and Average direction suggests the downtrend lacks conviction but is persistent enough to warrant caution, creating an uncertain technical environment as earnings approach.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $19.79 | 50-Day MA | $20.26 |
| 10-Day MA | $20.24 | 100-Day MA | $21.78 |
| 20-Day MA | $20.83 | 200-Day MA | $21.35 |
The stock is positioned below all major moving averages except the 5-day, trading at $19.82 versus the 10-day ($20.24), 20-day ($20.83), 50-day ($20.26), 100-day ($21.78), and 200-day ($21.35). This configuration represents a classic bearish alignment, with the stock failing to hold support at progressively longer timeframes. The only positive is the stock trading slightly above its 5-day moving average ($19.79), suggesting some very short-term stabilization. However, the overall technical setup is cautionary heading into earnings, with the stock down nearly 7% from its 200-day average and all timeframe signals flashing sell. Investors should be aware that the technical backdrop provides little cushion if results or guidance disappoint, though a strong beat could trigger a sharp reversal given the oversold conditions and substantial analyst price target upside.